This report highlights a very rare phenomenon of widespread psammomatous calcification without accompanying epithelium, present in the background of a uterine serous carcinoma. Psammomatous calcification is associated with benign and malignant pathology in different organ systems including the gynaecological tract.
ParwaniAVChanTYAliSZ. Significance of psammoma bodies in serous cavity fluid. Cancer. 2004;102:87-91.
2.
KumarVAbbasAFaustoNAsterJ. Robbins and Cotran Pathologic Basis of Disease. 8th ed.Philadelphia, PA: Elsevier Saunders; 2010:38.
3.
PusiolTGrazia ZorziMMorichettiDPiscoliIScialpiM. Peritoneal malignant psammomatous mesothelioma. World J Oncol. 2010;1:179-181.
4.
CameronRIMcCluggageWG. Extensive psammomatous calcification of the uterus and cervix associated with a uterine serous carcinoma. J Clin Pathol. 2004;57:888-890.
5.
PusiolTParolariAMPiscoliIMorelliLDel NonnFLicciS. Prevalence and significance of psammoma bodies in cervicovaginal smears in a cervical cancer screening program with emphasis on a case of primary bilateral ovarian psammomacarcinoma. Cytojournal. 2008;5:7.
6.
DasDKMallikMKHajiBE. Psammoma body and its precursors and papillary thyroid carcinoma: a study by fine needle aspiration cytology. Diagn Cytopathol. 2004;31:380-386.
HayesSJMisfarNSladeRMamtoraHWilsonG. Extensive pelvic calcification in association with ovarian serous cystadenofibroma. J Obstet Gynaecol Res. 2008;34:709-712.
9.
QizilbashAH. Ovarian carcinoma identified by psammoma bodies in the cervicovaginal and endometrial smears. Can Med Assoc J. 1974;10:185-186.
10.
ZinsserKRWheelerJE. Endosalpingiosis in the omentum: a study of autopsy and surgical material. Am J Surg Pathol. 1998;22:849-862.
11.
DasDK. Psammoma body: a product of dystrophic calcification or of a biologically active process that aims at limiting the growth and spread of tumour?Diagn Cytopathol. 2009;37:534-541.
12.
HerboldDRMagraneDM. Calcification of a benign endometrium. Arch Pathol Lab Med. 1986;110:666-669.
13.
FausettMBZahCMKendallBSBarthWHJr. The significance of psammoma bodies that are found incidentally during endometrial biopsy. Am J Obstet Gynecol. 2002;186:180-183.
14.
GoldsteinNSUziebloA. WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinoma. Am J Clin Pathol. 2002;117:541-545.
15.
FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103-104.
16.
ZreikTGRutherfordTJ. Psammoma bodies in cervicovaginal smears. Obstet Gynecol. 2001;97:693-695.
17.
GosdenCRossALoudenNB. Intrauterine deposition of calcium on copper bearing intrauterine contraceptive devices. BMJ. 1977;21:550-552.
HudelistGSingerCFKubistaE. Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoural biomineralisation. Histopathology. 2004;45:633-637.
